Lipoxin A4

Lipoxin a4 is a lipid of Fatty Acyls (FA) class. Lipoxin a4 is associated with abnormalities such as Asthma, Cystic Fibrosis, Pneumonia, Obesity and Septicemia. The involved functions are known as Inflammation, Signal, Signal Transduction, Regulation and Metabolic Inhibition. Lipoxin a4 often locates in Immune system, Blood, soluble, Extracellular and Splenic Tissue. The associated genes with Lipoxin A4 are FPR2 gene, Homologous Gene, SAA1 gene, Trp-Lys-Tyr-Met-Val-Met and Annexin 1. The related lipids are Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Lipoxin A4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Lipoxin A4?

Lipoxin A4 is suspected in Asthma, Cystic Fibrosis, Chagas Cardiomyopathy, Pneumonia, Obesity, Septicemia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Lipoxin A4

MeSH term MeSH ID Detail
Tuberculosis D014376 20 associated lipids
Stomach Ulcer D013276 75 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Lung Diseases D008171 37 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Per page 10 20 50 100 | Total 53

PubChem Associated disorders and diseases

What pathways are associated with Lipoxin A4

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Lipoxin A4?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Lipoxin A4?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Lipoxin A4?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Lipoxin A4?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Lipoxin A4?

Knock-out

Knock-out are used in the study 'Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice.' (Ortiz-Muñoz G et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Lipoxin A4

Download all related citations
Per page 10 20 50 100 | Total 639
Authors Title Published Journal PubMed Link
Maderna P et al. Lipoxins induce actin reorganization in monocytes and macrophages but not in neutrophils: differential involvement of rho GTPases. 2002 Am. J. Pathol. pmid:12057930
Romano M et al. Urinary excretion of lipoxin A(4) and related compounds: development of new extraction techniques for lipoxins. 2002 Lab. Invest. pmid:12218086
Vaughn MW et al. Identification, cloning, and functional characterization of a murine lipoxin A4 receptor homologue gene. 2002 J. Immunol. pmid:12218158
József L et al. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes. 2002 Proc. Natl. Acad. Sci. U.S.A. pmid:12235371
Fiorucci S et al. Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage. 2002 Gastroenterology pmid:12404234
Christophe T et al. Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1/LXA4R, is not affected by lipoxin A4. 2002 Scand. J. Immunol. pmid:12410796
Aliberti J et al. Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. 2002 J. Exp. Med. pmid:12417634
Schottelius AJ et al. An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile. 2002 J. Immunol. pmid:12471142
Bonnans C et al. Lipoxins are potential endogenous antiinflammatory mediators in asthma. 2002 Am. J. Respir. Crit. Care Med. pmid:12045128
Fierro IM et al. Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A(4) and lipoxin A(4). 2002 J. Pharmacol. Exp. Ther. pmid:11805195
Fierro IM and Serhan CN Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins. 2001 Braz. J. Med. Biol. Res. pmid:11323741
Wada K et al. Inosine monophosphate and aspirin-triggered 15-epi-lipoxin A4 act in concert to regulate neutrophil trafficking: additive actions of two new endogenous anti-inflammatory mediators. 2001 J. Hematother. Stem Cell Res. pmid:11276361
Goulet JL et al. Deficiency of 5-lipoxygenase accelerates renal allograft rejection in mice. 2001 J. Immunol. pmid:11714834
McMahon B et al. Lipoxins: revelations on resolution. 2001 Trends Pharmacol. Sci. pmid:11478982
Qiu FH et al. Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils. 2001 FASEB J. pmid:11687510
Levy BD et al. Lipid mediator class switching during acute inflammation: signals in resolution. 2001 Nat. Immunol. pmid:11429545
Gronert K et al. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses. 2001 Am. J. Pathol. pmid:11141472
Serhan CN et al. Cutting edge: nociceptin stimulates neutrophil chemotaxis and recruitment: inhibition by aspirin-triggered-15-epi-lipoxin A4. 2001 J. Immunol. pmid:11238602
Goh J et al. Lipoxin A(4) and aspirin-triggered 15-epi-lipoxin A(4) antagonize TNF-alpha-stimulated neutrophil-enterocyte interactions in vitro and attenuate TNF-alpha-induced chemokine release and colonocyte apoptosis in human intestinal mucosa ex vivo. 2001 J. Immunol. pmid:11509622
Wardle N New vistas in anti-inflammatory therapy. 2001 Nephron pmid:11474222
Godson C et al. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. 2000 J. Immunol. pmid:10657608
Clish CB et al. Local and systemic delivery of an aspirin-triggered lipoxin stable analog inhibits neutrophil trafficking. 2000 Ann. N. Y. Acad. Sci. pmid:10818463
Clish CB et al. Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation. 2000 J. Biol. Chem. pmid:10837478
Kang Y et al. Mutations of serine 236-237 and tyrosine 302 residues in the human lipoxin A4 receptor intracellular domains result in sustained signaling. 2000 Biochemistry pmid:11063592
McMahon B et al. Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors. 2000 J. Biol. Chem. pmid:10869343
Serhan CN and Clish CB Aspirin triggered lipid mediators: novel inhibitors of leucocyte trafficking. 2000 Thorax pmid:10992546
Gewirtz AT and Madara JL Lipoxin-stable analogs: potential therapeutic downregulators of intestinal inflammation. 2000 Ernst Schering Res. Found. Workshop pmid:10943333
Maderna P et al. Influence of lipoxin A(4) and other lipoxygenase-derived eicosanoids on tissue factor expression. 2000 Am. J. Physiol., Cell Physiol. pmid:11003574
Chiang N et al. Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. 2000 J. Exp. Med. pmid:10748237
Bandeira-Melo C et al. Cutting edge: lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking. 2000 J. Immunol. pmid:10679058
Sodin-Semrl S et al. Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. 2000 J. Immunol. pmid:10679106
Pouliot M et al. Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. 2000 Biochemistry pmid:10769133
Bandeira-Melo C et al. Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia. 2000 J. Immunol. pmid:10623853
Tornhamre S et al. 15-Lipoxygenation of leukotriene A(4). Studies Of 12- and 15-lipoxygenase efficiency to catalyze lipoxin formation. 2000 Biochim. Biophys. Acta pmid:10760478
Desplat V et al. Effects of lipoxygenase metabolites of arachidonic acid on the growth of human blood CD34(+) progenitors. 2000 Blood Cells Mol. Dis. pmid:11112380
Sanak M et al. Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. 2000 Eur. Respir. J. pmid:10933083
Denizot Y et al. Effect of cytokines and lipid mediators on the synthesis of interleukin 1 beta by human bone marrow stromal cells. 2000 Cytokine pmid:10857767
Kikuta Y et al. Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14. 2000 Arch. Biochem. Biophys. pmid:11185557
Kikuta Y et al. Purification and characterization of recombinant rat hepatic CYP4F1. 1999 Arch. Biochem. Biophys. pmid:10486137
Bratt J and Heimbürger M Prednisolone interferes with neutrophil adhesion and neutrophil mediated endothelial injury. 1999 Scand. J. Rheumatol. pmid:10568428
Filep JG et al. Anti-inflammatory actions of lipoxin A(4) stable analogs are demonstrable in human whole blood: modulation of leukocyte adhesion molecules and inhibition of neutrophil-endothelial interactions. 1999 Blood pmid:10590058
Pouliot M and Serhan CN Lipoxin A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor-alpha-initiated neutrophil responses and trafficking: novel regulators of a cytokine-chemokine axis relevant to periodontal diseases. 1999 J. Periodont. Res. pmid:10685363
Titos E et al. Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A(4). 1999 Am. J. Physiol. pmid:10564079
Clish CB et al. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10393980
Desplat V et al. Incorporation and effect of arachidonic acid on the growth of human myeloma cell lines. 1999 Mediators Inflamm. pmid:10704149
Besse A et al. Prostaglandin E2 regulates macrophage colony stimulating factor secretion by human bone marrow stromal cells. 1999 Biochim. Biophys. Acta pmid:10395955
Levy BD et al. Polyisoprenyl phosphate (PIPP) signaling regulates phospholipase D activity: a 'stop' signaling switch for aspirin-triggered lipoxin A4. 1999 FASEB J. pmid:10224233
Serhan CN et al. Lipoxin and aspirin-triggered 15-epi-lipoxin cellular interactions anti-inflammatory lipid mediators. 1999 Clin. Chem. Lab. Med. pmid:10353476
Schaldach CM et al. Lipoxin A4: a new class of ligand for the Ah receptor. 1999 Biochemistry pmid:10360957
Hachicha M et al. Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis. 1999 J. Exp. Med. pmid:10377187
Gewirtz AT et al. LXA4, aspirin-triggered 15-epi-LXA4, and their analogs selectively downregulate PMN azurophilic degranulation. 1999 Am. J. Physiol. pmid:10199831
Serhan CN et al. Aspirin-triggered 15-epi-lipoxin A4 and stable analogs on lipoxin A4 are potent inhibitors of acute inflammation. Receptors and pathways. 1999 Adv. Exp. Med. Biol. pmid:10086190
Lin KT et al. Modulation of LTB4 receptor in T-lymphocytes by lipoxin A4 (LXA4) and its role in delayed-type hypersensitivity. 1999 Adv. Exp. Med. Biol. pmid:10086191
Chiang N et al. Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. 1999 J. Clin. Invest. pmid:10430612
Spokas EG et al. Leukotrienes, lipoxins, and hydroxyeicosatetraenoic acids. 1999 Methods Mol. Biol. pmid:10343320
Hill DJ et al. Trout thrombocytes contain 12- but not 5-lipoxygenase activity. 1999 Biochim. Biophys. Acta pmid:9931438
Nassar GM and Badr KF Novel approaches to treatment of glomerulonephritis. 1998 Jul-Aug J. Nephrol. pmid:9702868
Takano T et al. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. 1998 J. Clin. Invest. pmid:9466977
Gronert K et al. Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release. 1998 J. Exp. Med. pmid:9547339
Gewirtz AT et al. Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs. 1998 J. Clin. Invest. pmid:9576749
Clària J et al. Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites. 1998 Gastroenterology pmid:9649470
Chiang N et al. Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA. 1998 J. Pharmacol. Exp. Ther. pmid:9808710
Gronert K et al. Characterization of human neutrophil and endothelial cell ligand-operated extracellular acidification rate by microphysiometry: impact of reoxygenation. 1998 J. Pharmacol. Exp. Ther. pmid:9536019
Takano T et al. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. 1997 J. Exp. Med. pmid:9151906
Serhan CN Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? 1997 Prostaglandins pmid:9112289
Scalia R et al. Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: role of P-selectin. 1997 Proc. Natl. Acad. Sci. U.S.A. pmid:9275235
Stahl GL et al. Eicosanoid production from porcine neutrophils and platelets: differential production with various agonists. 1997 Am. J. Physiol. pmid:9227410
Maddox JF et al. Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. 1997 J. Biol. Chem. pmid:9054386
Levy BD et al. Agonist-induced lipoxin A4 generation in vitro and in aspirin-sensitive asthmatics: detection by a novel lipoxin A4-ELISA. 1997 Adv. Exp. Med. Biol. pmid:9547611
Lin KT et al. Identification and characterization of a high-affinity leukotriene B4 receptor on guinea pig T lymphocytes and its regulation by lipoxin A4. 1996 J. Pharmacol. Exp. Ther. pmid:8627545
Chung-a-on KO et al. Stimulation of protein kinase C redistribution and inhibition of leukotriene B4-induced inositol 1,4,5-trisphosphate generation in human neutrophils by lipoxin A4. 1996 Br. J. Pharmacol. pmid:8882633
Hébert MJ et al. Sequential morphologic events during apoptosis of human neutrophils. Modulation by lipoxygenase-derived eicosanoids. 1996 J. Immunol. pmid:8816421
Feng Z et al. Leukotriene B4 modulates in vivo expression of delayed-type hypersensitivity by a receptor-mediated mechanism: regulation by lipoxin A4. 1996 J. Pharmacol. Exp. Ther. pmid:8768752
Tang DG et al. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. 1996 Proc. Natl. Acad. Sci. U.S.A. pmid:8643560
Romano M et al. Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization. 1996 J. Immunol. pmid:8757340
Papayianni A et al. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. 1996 J. Immunol. pmid:8690917
Maddox JF and Serhan CN Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. 1996 J. Exp. Med. pmid:8551217
Badr KF Lipoxygenases as therapeutic targets in the acute and subacute phases of glomerular immune injury. 1996 Contrib Nephrol pmid:8744048
Mayadas TN et al. Acute passive anti-glomerular basement membrane nephritis in P-selectin-deficient mice. 1996 Kidney Int. pmid:8731099
Brady HR Complex roles for P-selectin in the pathophysiology of glomerulonephritis. 1996 Curr. Opin. Nephrol. Hypertens. pmid:8937811
Serhan CN and Romano M Lipoxin biosynthesis and actions: role of the human platelet LX-synthase. 1995 J Lipid Mediat Cell Signal pmid:8777573
Tamaoki J et al. Lipoxin A4 inhibits cholinergic neurotransmission through nitric oxide generation in the rabbit trachea. 1995 Eur. J. Pharmacol. pmid:8991795
Bratt J and Gyllenhammar H The role of nitric oxide in lipoxin A4-induced polymorphonuclear neutrophil-dependent cytotoxicity to human vascular endothelium in vitro. 1995 Arthritis Rheum. pmid:7779119
Lee TH Lipoxin A4: a novel anti-inflammatory molecule? 1995 Thorax pmid:7701445
Serhan CN et al. Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. 1995 Biochemistry pmid:7578068
Bratt J et al. Mechanisms for lipoxin A4-induced neutrophil-dependent cytotoxicity for human endothelial cells. 1995 J. Lab. Clin. Med. pmid:7602232
Papayianni A et al. Transcellular biosynthesis of lipoxin A4 during adhesion of platelets and neutrophils in experimental immune complex glomerulonephritis. 1995 Kidney Int. pmid:7543622
Edenius C et al. Stimulation of lipoxin synthesis from leukotriene A4 by endogenously formed 12-hydroperoxyeicosatetraenoic acid in activated human platelets. 1994 Biochim. Biophys. Acta pmid:8305492
Serhan CN and Fiore S Lipoxin recognition sites of human neutrophils. 1994 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:7771345
Soyombo O et al. Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. 1994 Allergy pmid:8037356
Bratt J et al. Lipoxin A4 induces neutrophil-dependent cytotoxicity for human endothelial cells. 1994 Scand. J. Immunol. pmid:8146594
Fiore S et al. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. 1994 J. Exp. Med. pmid:8006586
Serhan CN et al. Cell-cell interactions in lipoxin generation and characterization of lipoxin A4 receptors. 1994 Ann. N. Y. Acad. Sci. pmid:7825838
Simchowitz L et al. Carrier-mediated transport of lipoxin A4 in human neutrophils. 1994 Am. J. Physiol. pmid:7810593
Levy BD et al. Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins. 1993 J. Clin. Invest. pmid:8376607
Lerner R et al. Lipoxin A4 induces hyperadhesiveness in human endothelial cells for neutrophils. 1993 Blood pmid:8393356
Romano M et al. Lipoxin synthase activity of human platelet 12-lipoxygenase. 1993 Biochem. J. pmid:8250832
Levy BD et al. Agonist-induced lipoxin A4 generation: detection by a novel lipoxin A4-ELISA. 1993 Lipids pmid:8121246
Sumimoto H et al. Formation of a novel 20-hydroxylated metabolite of lipoxin A4 by human neutrophil microsomes. 1993 FEBS Lett. pmid:8422907
Fiore S et al. Induction of functional lipoxin A4 receptors in HL-60 cells. 1993 Blood pmid:8389617